Real-World Cost-Effectiveness of Oxaliplatin in Stage III Colon Cancer: A Synthesis of Clinical Trial and Daily Practice Evidence

Chantal van Gils, Saskia de Groot, Ken Redekop, M Koopman, CJA Punt, Carin Uyl - de Groot

Research output: Contribution to journalArticleAcademicpeer-review

13 Citations (Scopus)
Original languageEnglish
Pages (from-to)703-718
Number of pages16
JournalPharmacoeconomics (Print)
Issue number8
Publication statusPublished - 9 May 2013

Cite this